Publications by authors named "J-P Schuster"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

2,552

Total Likes

392

Extended Reach

4,831,823

Social Features

180
W
Western Trauma Association critical decisions in trauma: Penetrating thoracic injury.
Manuel Lorenzo, Raul Coimbra, Chasen A Croft, Jennifer L Hartwell, Kevin S Schuster

J Trauma Acute Care Surg· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL.
Rakesh Awasthi, Stephan A Grupp, Edward R Waldron, Gregory A Yanik, Constantine S Tam, Stephen J Schuster

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics".
Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe, Pauline Dürr, Melanie I Straubmeier, Anna K Schuster

Br J Clin Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis.
Peter A Riedell, Connor B Grady, Loretta J Nastoupil, Alejandro Luna, Nausheen Ahmed, Stephen J Schuster

Blood Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-factor prothrombin complex concentrate is not inferior to andexanet alfa for the reversal or oral factor Xa inhibitors: An Eastern Association for the Surgery of Trauma multicenter study.
Jordan M Estroff, Joseph Devlin, Lara Hoteit, Adnan Hassoune, Matthew D Neal, Kevin M Schuster

J Trauma Acute Care Surg· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel.
Nausheen Ahmed, William Wesson, Forat Lutfi, David L Porter, Veronika Bachanova, Stephen J Schuster

Blood Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Martin Dreyling, Nathan Hale Fowler, Michael Dickinson, Joaquin Martinez-Lopez, Arne Kolstad, Stephen J Schuster

Blood· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma.
Samuel Yamshon, Gui Zhen Chen, Caitlin Gribbin, Paul Christos, Bijal Shah, Stephen J Schuster

Blood Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome.
Shakthi T Bhaskar, Vivek G Patel, David L Porter, Stephen J Schuster, Loretta J Nastoupil

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma.
Michael Scordo, Jessica R Flynn, Mithat Gonen, Sean M Devlin, Allison Parascondola, Stephen J Schuster

Blood Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency.
Jana Block, Christina Rashkova, Irinka Castanon, Samaneh Zoghi, Jessica Platon, Michael Schuster

N Engl J Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy.
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, Sean M Devlin, Jamie Brower, Stephen J Schuster

Blood Adv· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCRvβ-CART therapy mediates high-precision targeting of malignant T-cell clones.
Lauren C Shaw, Mathilde Poussin, Alba Rodriguez-Garcia, Joshua Eggold, Nicholas G Minutolo, Stephen J Schuster

Blood Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Nerve Stimulation for Chronic Pain and Migraine: A Review.
Samantha C Erosa, Roya S Moheimani, Jessica C Oswald, Joel P Castellanos, Mickey E Abraham, Nathaniel M Schuster

Phys Med Rehabil Clin N Am· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
Michael R Bishop, Michael Dickinson, Duncan Purtill, Pere Barba, Armando Santoro, Stephen J Schuster

N Engl J Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Approach for the Treatment of T Cell Malignancies: Targeting T Cell Receptor Vβ Families.
Jie Wang, Katarzyna Urbanska, Prannda Sharma, Reza Nejati, Lauren Shaw, Stephen J Schuster

Vaccines (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion.
Michael R Bishop, Richard T Maziarz, Edmund K Waller, Ulrich Jäger, Jason R Westin, Stephen J Schuster

Blood Adv· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Stephen J Schuster, Michael R Bishop, Constantine S Tam, Edmund K Waller, Peter Borchmann

N Engl J Med· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma.
Jia Ruan, Peter Martin, Paul Christos, Leandro Cerchietti, Wayne Tam, Stephen J Schuster

Blood· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.
Ingo Kleiter, Anna Gahlen, Nadja Borisow, Katrin Fischer, Klaus-Dieter Wernecke, Simon Schuster

Neurol Neuroimmunol Neuroinflamm· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can acute care surgeons perform while fatigued? An EAST multicenter study.
Kevin M Schuster, Joshua P Hazelton, Deviney Rattigan, Linh Nguyen, Dennis Kim

J Trauma Acute Care Surg· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity of Network Structures and Water Dynamics in κ-Carrageenan Gels Probed by Nanoparticle Diffusometry.
Daan W de Kort, Erich Schuster, Freek J M Hoeben, Ryan Barnes, Meike Emondts

Langmuir· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[What’s new in psychiatry of the elderly].
Stéphane Mouchabac, Jean-Pierre Schuster, Alexis Bourla, Florian Ferreri

Rev Prat· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TDP-43 pathology and cognition in ALS: A prospective clinicopathologic correlation study.
Johannes Prudlo, Jochem König, Christina Schuster, Elisabeth Kasper, Andreas Büttner

Neurology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis